Crinetics Pharmaceuticals CRNX Business Segments — External Selling, General And Administrative Expenses

Similar metrics at other companies

CENXReportable Segment — Selling, general and administrative expenses

$25.8M+106%

EOSEReportable Segment — Selling, general and administrative expenses

$21.28M+41.7%

TWSTReportable Segment — Selling, general and administrative expenses

$59.26M+25.3%

ALHCReportable Segment — Selling, general, and administrative expenses

$108.53M+23.6%

GXOReportable Segment — Selling, general and administrative expense

$280M+13.8%

WSCReportable Segment — Employee Selling, General And Administrative Expense

$71.71M+5.0%

Questions, answered.

What is Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses?

Crinetics Pharmaceuticals (CRNX) reported business segments — external selling, general and administrative expenses of $20.44M in Q1 2026.

How has Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses changed year-over-year?

Crinetics Pharmaceuticals's business segments — external selling, general and administrative expenses increased by 38.4% year-over-year, from $14.77M to $20.44M.

What does business segments — external selling, general and administrative expenses mean?

This metric tracks third-party costs associated with selling, general, and administrative functions, such as marketing, legal, and professional services. It reflects the external operational support required to manage the business and prepare for commercial product launches. Monitoring this provides insight into the company's commercial infrastructure and administrative overhead.